News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ionix Pharmaceuticals Patents Granted On Novel Analgesic Program: Series C Financing Initiated


10/19/2005 5:08:47 PM

Ionix Pharmaceuticals, a leader in the discovery and development of analgesic drugs, today announced that it has been granted further patent protection in support of its programmes to develop analgesics that modulate the sodium channel drug target, Nav1.8. On May 26, Ionix was granted two patents which cover proteins that regulate the expression of this target. These inventions form the basis of the company's IX-4000 drug discovery programme for the treatment of chronic pain and urological disorders.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES